FDA issues CRL for MDMA therapy for PTSD treatment Drug Discovery & Developmentsource Post navigation Kaya Holdings, Inc. (OTCQB:KAYS) Criticizes FDA Rejection of MDMA Therapy for PTSD, Proposes Psilocybin as Alternative Treatment – AccessWireFDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face – The Conversation Indonesia